194 related articles for article (PubMed ID: 26393913)
41. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
[TBL] [Abstract][Full Text] [Related]
42. Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancer.
Lin Q; Xie D; Pan L; Lou Y; Shi M
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34580719
[TBL] [Abstract][Full Text] [Related]
43. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues.
Esfandi F; Taheri M; Omrani MD; Shadmehr MB; Arsang-Jang S; Shams R; Ghafouri-Fard S
BMC Cancer; 2019 Mar; 19(1):222. PubMed ID: 30866866
[TBL] [Abstract][Full Text] [Related]
44. Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
Xian J; Zeng Y; Chen S; Lu L; Liu L; Chen J; Rao B; Zhao Z; Liu J; Xie C; Zhu L; Zhang D; Qiu F; Lu J; Yang L
Carcinogenesis; 2021 Jun; 42(6):831-841. PubMed ID: 33928340
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?
Osielska MA; Jagodziński PP
Biomed Pharmacother; 2018 May; 101():322-333. PubMed ID: 29499406
[TBL] [Abstract][Full Text] [Related]
46. Long intergenic noncoding RNA LINC00173 as a potential serum biomarker for diagnosis of non-small-cell lung cancer.
Yang Q; Kong S; Zheng M; Hong Y; Sun J; Ming X; Gu Y; Shen X; Ju S
Cancer Biomark; 2020; 29(4):441-451. PubMed ID: 32623390
[TBL] [Abstract][Full Text] [Related]
47. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
[TBL] [Abstract][Full Text] [Related]
48. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs.
Wang P; Lu S; Mao H; Bai Y; Ma T; Cheng Z; Zhang H; Jin Q; Zhao J; Mao H
Lung Cancer; 2015 May; 88(2):147-53. PubMed ID: 25758555
[TBL] [Abstract][Full Text] [Related]
49. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
50. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
51. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer.
Liu HY; Lu SR; Guo ZH; Zhang ZS; Ye X; Du Q; Li H; Wu Q; Yu B; Zhai Q; Liu JL
J Investig Med; 2020 Jan; 68(1):52-59. PubMed ID: 31371390
[TBL] [Abstract][Full Text] [Related]
52. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
Zhou D; Xie M; He B; Gao Y; Yu Q; He B; Chen Q
Mol Med Rep; 2017 Oct; 16(4):5129-5136. PubMed ID: 28849055
[TBL] [Abstract][Full Text] [Related]
53. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
54. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
55. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
56. Expression Analysis of OIP5-AS1 in Non-Small Cell Lung Cancer.
Esfandi F; Kholghi Oskooei V; Taheri F; Kiani A; Taheri M; Ghafouri-Fard S
Klin Onkol; 2018; 31(4):260-263. PubMed ID: 30541307
[TBL] [Abstract][Full Text] [Related]
57. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
59. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
60. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]